Drug discovery

Accelerated drug discovery

A novel hybrid platform combining Quantum inspired technology, Machine Learning and advanced physics simulations improving both speed and chemical diversity in designing novel virtual candidates. Our platform creates a target bespoke virtual library, containing billions of molecules, all designed to hit the Clinical Research Organisation’s specific target, achieving de novo molecule discovery while minimising timescales.

The technology powering the small molecule drug discovery platform

At the heart of Fujitsu’s Drug Discovery Offering is the Digital Annealer. The Quantum-inspired Digital Annealer solves combinatorial optimisation problems orders of magnitude faster than any other currently available alternatives. It is based on custom hardware, is production ready and incorporates Quantum-like processes and algorithms. Forward looking customers are using the Digital Annealer (DA) to help prepare their computational strategy for the Quantum Revolution.

Customer stories

Digital Health Enterprise Interoperability Platform

Fujitsu led the implementation of a cloud hosted Enterprise Interoperability Platform (EIP) for a large Government agency responsible for the management of the public health system.

A woman carrying a young boy depicting healthcare interoperability

Evolution of Enterprise Data Management in Health

The State Health System chose Fujitsu to design, build and maintain a Health Information Exchange (HIE) platform for financial and clinical reporting assets.

Woman looking out the shopfront depicting evolution of enterprise data management

Related content

SAP Integrated Business Planning

Fujitsu is a Supply Chain certified partner of SAP Digital Supply Chain (SAP IBP). We help our clients transform enterprise business processes using integrated digital supply chain.

SAP Digital Manufacturing Cloud (DMC) on Azure

SAP Digital Manufacturing Cloud (DMC) optimises manufacturing performance by integrating production execution, visibility and analysis.